ReviewTherapeutic advances in medical oncology2020

Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion.

Quincy S ChuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.